Northwestern Mutual Wealth Management’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History
Bought
Maintained
Sold
Other funds holding STLN
VCM
DM
KWM
JAIC
WC
CP
Northwestern Mutual Wealth Management's STLN Position: Q1 2026 in Review
Northwestern Mutual Wealth Management sold out of Starling Oncology Institute, Inc. Common Stock (STLN) in Q1 2026, closing a stake of 8 shares — an estimated $28 sold.
Northwestern Mutual Wealth Management first reported a position in STLN in Q4 2025 and held it in 1 quarter. The position peaked at $28 in Q4 2025. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.
- Northwestern Mutual Wealth Management reported no remaining Starling Oncology Institute, Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
- Northwestern Mutual Wealth Management sold 8 Starling Oncology Institute, Inc. Common Stock shares in Q1 2026, an estimated $28.
- Northwestern Mutual Wealth Management first reported a position in Starling Oncology Institute, Inc. Common Stock in Q4 2025 and held it in 1 quarter.
- Northwestern Mutual Wealth Management's Starling Oncology Institute, Inc. Common Stock position peaked at $28 in Q4 2025.
- 115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.